Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2005
10/18/2005US6956116 Pesticidal toxins and genes from Bacillus laterosporus strains
10/18/2005US6956115 Nucleic acid molecules from rice encoding RAR1 disease resistance proteins and uses thereof
10/18/2005US6956112 Fluorescent protein; for use as a diagnostic tool in the treatment of cancer, inflammation and apoptosis defects
10/18/2005US6956110 Genes involved in the molecular paths of tumor suppression and/or resistance to viruses
10/18/2005US6956106 Ti-3 protein derived from triatoma infestans exhibiting activity to inhibit platelet aggregation
10/18/2005US6956105 Chandra: a Th1-specific protein
10/18/2005US6956104 Proteins for use in the treatment and diagnosis of brain and nervous system disorders
10/18/2005US6956103 Glaucoma therapeutics and diagnostics
10/18/2005US6956102 Human N-methyl-D-aspartate receptor subunits nucleic acids encoding same and uses therefor
10/18/2005US6956051 amphiphilic drug-oligomer conjugates comprising a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety; therapeutic agents coupled to amphiphilic oligomers
10/18/2005US6956027 N-terminally chemically modified protein compositions and methods
10/18/2005US6956026 Use of exendins for the reduction of food intake
10/18/2005US6956025 Crosslinked hemoglobin immobilized on polyoxyethylene glycol
10/18/2005US6956023 Materials and methods for providing nutrition to neonates
10/18/2005US6955916 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
10/18/2005US6955913 spray drying; heating; for use in cosmetics/shampoos
10/18/2005US6955905 PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use
10/18/2005US6955899 comprises collagen-like domain; tissue remodeling
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955897 Number of accessory gland proteins from Drosophila. The invention also provides an accessory gland protein which is toxic to insect cells and can be used to kill or inhibit the development of insects. Methods of controlling insects are
10/18/2005US6955895 Nucleic acid encoding the receptor; use drug screening
10/18/2005US6955894 cytokines; for increasing/decreasing signal transduction; metalloproteases; for treating inflammation during treatment of septic shock, arthritis, and/or multiple sclerosis
10/18/2005US6955891 Reagents for assaying Bacillus anthracis lethal factor protease
10/18/2005US6955887 Use of T1R hetero-oligomeric taste receptor to screen for compounds that modulate taste signaling
10/18/2005US6955885 Human stanniocalcin-alpha
10/18/2005US6955884 Nucleotide sequences coding protein for use in the treatment of inflammation, graft rejection, ischemia, asthma, autoimmune disease, diabetes, arthritis, and infection
10/18/2005US6955875 Diagnosis or determining genetic susceptibility by determining the presence of a mutation in exon 2 or in an intron of an HFE nucleic acid; hemochromatosis
10/18/2005US6955811 Methods of inhibiting immune response suppression by administering antibodies to OX-2
10/18/2005US6955808 Capsid-modified recombinant adenovirus and methods of use
10/18/2005US6955807 IL-2 selective agonists and antagonists
10/18/2005CA2338820C Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression
10/18/2005CA2184386C Interference eliminating agent for application in immunoassays
10/18/2005CA2006929C Cloning and production of polypeptide analogs of human fibronectin and methods of using such polypeptide analogs
10/13/2005WO2005095975A2 Anti-fungal target genes
10/13/2005WO2005095962A1 Method for immobilizing polypeptides and solid supports having polypeptides immobilized thereon
10/13/2005WO2005095632A2 Methods for identifying proteins with starch phosphorylating enzymatic activity
10/13/2005WO2005095627A2 Method for producing purine nucleosides and nucleotides by fermentation using bacterium belonging to the genus bacillus or escherichia
10/13/2005WO2005095625A1 Arabinogalactan protein compositions and methods for fostering somatic embryogenic competence
10/13/2005WO2005095624A2 Filamentous fungal mutants with improved homologous recombination efficiency
10/13/2005WO2005095620A2 Methods and compositions for regulating plant stress tolerance
10/13/2005WO2005095614A1 Genes involved in plant fibre development
10/13/2005WO2005095612A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/13/2005WO2005095611A1 Method for the recombinant expression of an n-terminal fragment of hepatocyte growth factor
10/13/2005WO2005095610A1 Nucleic acid expressed in the hypothalamus or muscle tissue and uses thereof in diagnoses
10/13/2005WO2005095609A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide
10/13/2005WO2005095608A1 Novel temperature regulated promoters and expression vectors from s.pombe
10/13/2005WO2005095603A1 Detection instrument with the use of polynucleotides mapped on barley chromosome
10/13/2005WO2005095600A1 Heparin-binding protein having heparan sulfate sugar chain attached thereto, process for producing the same and medicinal composition containing the same
10/13/2005WO2005095599A1 Novel fluorescent protein and gene encoding the same
10/13/2005WO2005095598A1 Cancer antigen peptide originating in wt1
10/13/2005WO2005095593A1 Method for modification of nmda receptors through inhibition of src
10/13/2005WO2005095591A2 Novel genes from a biosynthesis gene cluster for aminoglycoside antibiotic synthesis and the thus obtained novel aminoglycoside antibiotics
10/13/2005WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same
10/13/2005WO2005095452A1 Calcium ion leakage inhibitors
10/13/2005WO2005095451A1 Nucleotide and amino acid sequences for ruminant epidermal growth factor
10/13/2005WO2005095450A2 Therapeutic use of a growth factor, nsg33
10/13/2005WO2005095449A1 Method for the purification of an n-terminal fragment of hepatocyte growth factor
10/13/2005WO2005095448A2 Method of synthesizing and purifying dkk proteins and dkk proteins obtained thereby
10/13/2005WO2005095447A2 Low molecular weight forms of foxp1 proteins and splice variants thereof
10/13/2005WO2005095446A1 Factor reca from bacillus licheniformis and reca-inactivated safety stems used for biotechnological production
10/13/2005WO2005095443A1 Drug delivery system using peptide modification
10/13/2005WO2005095439A1 Process for producing solubilized keratin
10/13/2005WO2005095413A1 Antitumor agent
10/13/2005WO2005095412A1 Antiallergic agent
10/13/2005WO2005094900A1 Preventive and/or remedy for cancer
10/13/2005WO2005094891A2 Method for solubilising peptide mixtures
10/13/2005WO2005094890A1 Composition for increasing body height
10/13/2005WO2005094875A1 Use of epi-hne 1-4
10/13/2005WO2005094872A1 Polypeptide inducing the secretion of angiopoietin
10/13/2005WO2005094871A2 Bmp-3 propeptides and related methods
10/13/2005WO2005094818A1 Azabicyclo-octane inhibitors of iap
10/13/2005WO2005094785A2 Compositions capable of facilitating penetration across a biological barrier
10/13/2005WO2005094571A1 Genetically modified hetero animal and method of measuring exocytosis using the animal
10/13/2005WO2005094569A1 Ion channel
10/13/2005WO2005094562A1 Plants having improved growth characteristics and method for making the same
10/13/2005WO2005094543A2 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
10/13/2005WO2005094533A2 Trail-r as a negative regulator of innate immune cell responses
10/13/2005WO2005094453A2 Cospeptin, cosmedin and their uses
10/13/2005WO2005094365A2 Ten-m3 polypeptides and polynucleotides and their methods of use
10/13/2005WO2005094356A2 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
10/13/2005WO2005094355A2 Methods for altering protein production rates
10/13/2005WO2005094278A2 N-acylated chitinous polymers and methods of use thereof
10/13/2005WO2005094259A2 Leptin binding domain compositions and methods thereto
10/13/2005WO2005094256A2 Polypeptides toxic to nematodes, and methods of use
10/13/2005WO2005094219A2 Unique chromosomal sequence of bacillus anthracis and methods of making and using thereof including real-time pcr assays
10/13/2005WO2005080420A3 Hyphal growth in fungi
10/13/2005WO2005063290A3 Use of il-18 binding protein in inflammations
10/13/2005WO2005056577A3 Peptide inhibitors of hiv
10/13/2005WO2005038035A3 Methods for producing and using in vivo pseudotyped retroviruses
10/13/2005WO2005035558A3 Piscirickettsia salmonis antigens and use thereof
10/13/2005WO2005029043A3 Rho antibody and tag to purify cell surface proteins
10/13/2005WO2005019474A3 Human autism susceptibility gene and uses thereof
10/13/2005WO2005014654A3 Product comprising a c4bp core protein and a monomeric antigen, and its use
10/13/2005WO2005010205A3 Biomarkers fo aggrecanase activity
10/13/2005WO2005009378A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/13/2005WO2005005638A3 High affinity fusion proteins (rc-scfv-fc or scfv-scfv-fc) binding cytokines, particularly il-6 & il-18
10/13/2005WO2004113371A3 Virulence-associated adhesins
10/13/2005WO2004092328A3 Novel beta-tubulin protein of candida glabrata and methods for its use
10/13/2005WO2004085466A8 Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use
10/13/2005WO2004084814A3 High viscosity xanthan polymer preparations
1 ... 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 ... 2916